C arcinom a of the u rin a ry b lad d er, after prostate cancer, is the m ost common malig nant tum or of the urinary tract in m en and w om en and accounts for 2 % of all m alignan cies. In 1993, in the U nited States 52,300 cases w ere registered. A lthough this num ber is still increasing because of aging of the population, sm oking behavior (the most im portant single risk factor) is also an obvious influence. For exam ple, b la d d e r cancer m ortality has d e creased since 1990 because of changes in sm oking behavior in the male Dutch popula tion for successive birth cohorts after 1930 (Liem eney LALM , W itjes JA, un p u b lish ed data). The m ortality in the United States in 1993 was 9900. Bladder cancer is seen pre dom inantly in elderly m en and the male to female ratio is 4:1.
A bout 90% to 95% of urinary bladder m a lignancies are tran sitio n al cell carcinom as, and the rem aining 5% to 10% consist of squa m ous cell carcinomas and adenocarcinomas and a small num ber of sarcomas and métasta sés from other prim ary tumors. About two thirds of the tum ors are superficial (< pT2 ) and are usually papillary. 15 One third of the tum ors show infiltration into or beyond the m uscular layer of the bladder wall.
The initial treatm ent and prognosis largely are determ ined by the depth of tum or infil tration (tum or stage); the presence of positive lym ph nodes and distant m etastases; a n d the histologic tum or type.14 Therefore, exact stag ing is imperative. 
MR IMAGING ANATOMY
The bladder wall consists of four layers: (1 ) the m ucosa or epithelium , (2 ) the lamina propria or subepithelial connective tissue, (3) the m uscle layer, and (4) the serosa. The mus cle layer consists of bundles of smooth muscle tissue and has an intermediate-signal inten sity, equal to that of skeletal muscle, on Tlw eighted images and a low-signal intensity on T2-weighted images. According to Narumi et al,20 the m uscular wall consists of two dif ferent layers. The muscle fibers of the outer layer are looser and are interspersed with loose collagen fibers, blood vessels, and adi pose tissue. Therefore, on T2-weighted in vitro MR images, the signal intensities of the outer bladder wall are higher. These findings, however, have been reported only on in vivo MR images in cases of bladder wall hypertro phy. At the site of the trigone, the wall con sists of an extra triangular layer of muscle. Bundles from this layer link the ureteric ostia, forming the interureteric riclge. The serosa is not a bona fide layer but is merely a perito neal covering, which., in fact, is in contact with the bladder only at the dome, which is just a small part of the entire bladder surface. The serosa is too thin to he recognized on MR images.
On T.1 -weighted, images, urine has a lowsignal intensity, whereas the perivesical fat has a high-signal intensity. Because urinary b 1 acl cler ca rc in om as ha v e a n in te rmed ia te-signal intensity, equal, to that of muscle, Tl~ weighted images are used to determine tu mor infiltration into the perivesical, fat ( Fig.  2 ) and to show the endoluminal tumor com ponent. T1-weighted images are also most suitable for imaging lymph nodes, the signal intensity of which is lower than that of the surrounding fatty tissue. Normal and abnor mal lymph nodes, however, show no differ ence in signal intensity on these images. Therefore, a normal lymph node on MR im ages can be defined only by its size and shape. The signal intensity of bone marrow métastasés is equal to that of the primary tumor; therefore, T1 -weighted images, on which there is a good contrast between these métastasés and the surrounding fatty bone marrow, are best for recognizing bone m ar row métastasés.
On T2~ weigh ted images, the perivesical fat has a low-or a high-signal intensity, d e pending on the type of sequence used. Urine has a high-signal intensity. The tumor has an intermediate-signal intensity, higher than bladder wall or fibrosis and lower than urine. The zonal anatomy of prostate or uterus and vagina also can be well recognized on these images. These images are used for determin ing depth of tum or infiltration within the bladder wall (Figs. 3 and 4) ; for differentiat ing tumor from fibrosis; for assessment of invasion into the prostate/ uterus, or vagina; and for confirming bone marrow métastasés seen on Tl-weightecl. images.
After intravenous administration of a gado linium contrast agent urinary bladder cancer shows earlier and greater enhancement than does normal bladder wall or other nonm alig nant tissues (Fig, 5 ) > 'to, 2). 22, 24. 27, no Further more, enhancement occurs earlier in bladder cancer than in edema and granulation tissue.s F ig u re 2. Axial T 1 -w eighted three-dim ensional M P-RAGE im age in a patient with stage T3b urinary bladder cancer. Tum or in fil trates the perivesical fat (arrows) up to pelvic piriform m uscle. eAjjBJlÜjui L|j¡AA iu 0iîed b ui (xujeuj \7ZOi X frSCH) 3 S i p9ji|6f9/w-si |b(xb uofinjosaj-LjöfH P säfiw'
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STAGING
MR imaging is unsuitable for diagnostic screening for bladder cancer because of its high cost, and cystoscopy remains the most appropriate method of detecting a bladder tumor. Once a bladder tumor is detected, staging is needed to plan therapy and prog nosis. Most important in this regard is the distinction between superficial tumors and tumors invading the muscular bladder wall. best technique for separating superficial tu mors (stage T'l) from, minimally invasive tu mors (stage T2).'tJ' 26 Transurethral resection also offers information about tumor histol ogy. Currently, with MR imaging, differentia tion of stage T1 from stage T2 is difficult. Therefore, staging usually begins with trans resection.
resection and bimanual examination, is the Patients with superficial tumors are treated with local endoscopic resection followed by intravesical instillations of chemotherapeutic agents, BCG therapy, or both. In these pa tients, no additional staging procedures are n e e d e d . A n exception could be m ade for sta g e T1 tu m o rs w ith a high m alignancy g rad e (grade III), because these tumors have a h ig h likelihood of progressing to an infil trative tum or or of metastasizing.
Patients w ith m uscle invasion, with per ivesical infiltration, or w ith invasion into prostate, vagina, or uterus (stages T2~T4a) m ay undergo radical lym phadenectom y and cystectomy. W hen pelvic side wall infiltration or tu m o r extension into the abdominal wall (stage T4b) or m etas tases are present, alone or in combination, surgery usually is not the first choice. Instead, neoadjuvant chemother apy o r p alliativ e ra d ia tio n th erap y is p re scribed. Therefore, preoperative recognition of pelvic side w all infiltration or metastases is im p o rta n t Because the accuracy of clinical s ta g in g in this m a tter is unreliable, other m eth o d s are required, CT scan seems to be a valuable addition in this setting. The overall p rim a ry staging accuracy ranges from 40% to 92% (mean, 74%).2' 3' 7~9' 13' 17' 18' ^25 The accu racy of MR im aging for prim ary tum or stag ing varies from 73% to 96% (mean, 85%), T hese values are 10% to 33% (mean, 19%) h ig h e r th a n those obtained w ith CT scan. Published data on the accuracy of MR imag in g com pared w ith that of CT scan for stag ing tu m o r and lym ph node metastases are su m m arized in Table 2 .
In staging ly m p h node metastases, MR im ag in g and CT scan are comparable w hen two dim ensional techniques are used; accuracy for CT scan is 83% to 97% (mean, 89%) versus 73% to 98% (mean, 89%) for MR imaging. W ith n ew th ree-d im en sio n al techniques, how ever, MR im aging results are promising (accuracy, 90%) (Jager GJ, Barentsz JO, Oosterhof GO, et al, unpublished data) . 4 Finally, MR im aging seems to have advantages over CT scan and nuclear bone scanning in the diagnosis of bone m arrow metastases (Fig.   6 ) . 1 ' 3 M uch interest has been generated by the possibility of using MR im aging to differenti ate betw een superficial (stage T2) and deep invasion of the muscle layer of the bladder wall (stage T3a). W ith clinical staging, CT scan, and intravesical sonography, this dis tinction cannot be m ade reliably. Most p u b lished reports indicate that these stages can be differentiated on unenhanced T2 -weighted im ages,3,9> n*25, 31 More recently, Nicolas et al, 24 Tachibana et al, 29 and Sparenberg et al, 28 show ed that the extent of invasion in the bladder wall is better delineated on postcon trast T l-w eig h ted im ages th an on u n e n hanced T2-weighted images. 26  80  73  none  Amendola et al2  10  40  90  IV, oral  11  73  91  none  KOper et al10 15 IV  12  75  none  Bryan et al8  9  67  89  IV, oral  10  80  90  none  Rholl et al25  19  85  95  IV  23  96  96  none  Nicolas et al23 161 82 Barentsz et al3  60  45  82  oral, recta!  60  85  96  none  Tavares et al31 34 
IV Barentsz et al4
------------- ----------- ------------ ------------ 28 93 93 IV Barentsz et al5 ------------- ------------ ------------ ------------
84 93 IV
Dash Indicates data not reported. IV = intravenous.
those of CT scan. In m ost centers, however, patients w ith stage T3a and stage T3b tumors are treated w ith cystectomy. Besides difficulties in distinguishing stage T1 tumors from stage T2 tumors, MR imaging has other limitations. Although differentia tion betw een late fibrosis and granulation tis sue and carcinoma is better w ith MR imaging than w ith CT scan an d ultrasound, differenti ation b etw een acute edem a or hyperem ia, present during the first weeks after transure thral resection, and tum or is difficult.6,10' 21' 22 ' 24, 28,29 Therefore, staging after transurethral resection is som ew hat inaccurate. This prob lem m ay be solved by using ultrafast dy namic sequences.5 A n alternative is to per form MR im ag in g before tran su reth ral resection. This strategy, however, results in unnecessary M R im aging examinations in all patients w ith superficial tumors, w ho make up two thirds of all patients w ith urinary bladder cancer. Taking into account the high cost and the lim ited availability of MR im aging time for abdom inal studies, this ap p ro ach does n o t seem acceptable for the health care system.
On the basis of published reports and the authors' ow n experience, Table 3 offers an overview of the value of the several staging techniques for urinary bladder cancer. MR im aging an d clinical staging com plem ent each other. MR im aging is the most accurate technique for differentiating between various stages of deeply infiltrating tumors (stages T2 and higher), w hereas clinical staging is the b est technique for differentiating betw een acute edema, early granulation tissue, and the various stages of superficial tumors (stages low er than T2). W hen MR im aging is avail able, CT scan is not needed.
NEW DEVELOPMENTS
Rapid im provem ents in h a rd w a re a n d soft ware, innovations in contrast agents, an d the use of MR im aging-guided b iopsy m ak e MR im aging an increasingly pow erftil tool for ra diologists and urologists.
Surface Coils
W ith new phased-array surface coils, a se ries of T2-weiglited high-re solution im ages can be m ade in 5 m inutes (see Fig. 4 ). For evaluating the extent of m uscle invasion, the combination of an external p h ased -array an d an endorectal coil w ith these pulse sequences seems promising.
Three-dimensional Sequences
At the present, a three-dim ensional d ata set can be obtained w ithin a short time. W ith the help of fast postprocessing techniques, such as m ultiplanar reconstruction, im ages can be reconstructed in every desired plane. The use of m ultiplanar reconstruction im proves local tum or staging.4 Local tum or grow th, ad h e sions and bow el w all invasion, an d bone m ar row m etastases can be visualized better than w ith conventional tw o-dim ensional M R im aging techniques. In a series of 28 patients, accuracy of prim ary staging im p ro v ed from 78% to 93°/o. Also with this technique, threedimensional information concerning lymph nodes can be obtained. Normal nodes mea suring 3 mm can be recognized, because the three-dimensional technique shows the size and shape of nodes. The maximal length and the axial size can be determined quantita tively, and round nodes can be distinguished from oval nodes by dividing the axial size by the length. Lymph nodes are considered to be enlarged pathologically when the index is more than 0.8 for a round node with a mini mal axial size of 8 mm or more (Fig. 7) , or when the index is less than 0.8 for an oval node with a minimal axial size of 10 mm or more (Fig. 8 ). An asymmetric cluster of small lymph nodes also is considered to be patho logic. When using these criteria in 134 pa tients with bladder (n = 71) or prostate can cer (n = 63), an accuracy of 90%, a specificity of 98%, a sensitivity of 75%, and a positive predictive value of 94% can be achieved (Jager GJ, Barents?, JO, Oosterhof GO, et al, unpublished data). Correct identification of pathologic nodes was possible in 33 cases; however, microscopic metastatic deposits in normal-sized nodes were not recognized in 11 patients. In only two patients with enlarged nodes without metastasis, a false-positive di agnosis was obtained. These results show that three-dimensional MR imaging can be used to select patients for MR imaging-or CT scan-guided biopsy or laparoscopic perito neal lymph node dissection.
Fast Dynamic Imaging
Urinary bladder cancer shows more and faster enhancement than bladder after injection of MR imaging contrast agents, probably because of tum or neovascularity. Fast dynamic sequences (one image per sec ond) allow evaluation of minimal differences in enhancement of bladder cancer and other structures. Urinary bladder cancer shows early enhancement beginning about 6 seconds after the initiation of arterial enhancement; the urinary bladder enhances about 4 seconds earlier than most other structures, including postbiopsy tissue. In a series of 61 patients, based on the beginning of enhancement, im proved accuracy (from 79% to 90%) and spec ificity (from 33'% to 92%) were obtained in differentiating postbiopsy tissue from malig nancy. Overall accuracy of tumor staging improved significantly, from 67% to 84% (p<0.01). 5 Métastasés in enlarged or normal-sized lymph, nodes may show early enhancement, equal to that of the primary bladder tumor (Fig. 9) ; therefore, recognition of métastasés in normal-sized nodes may be possible. Current limitations of this technique, such as the in ability to image at more than one level with
Text continued on page 599 F igure 7. Patient with infiltrative (stage T2) urinary bladder cancer and nodal metastases. A, T1-weighted MP-RAGE image in plane parallel to right iliac vessels (v = vein; a = artery) shows lymph node with length of 10 mm (circle). B, T1-weighted reconstructed plane perpendicular to longitudinal axis of node shows axial size of 9 mm. index is 0.9, which suggests a round node; therefore, the axial size of 9 mm is abnormal. Histology confirmed metastases. Illustration continued on opposite page
• " , S * <*>;> this high speed, will be overcome in the fu ture. Initial experim ents already show that fast dynamic im aging is possible at four lev els (Fig. 10) . These fast dynam ic sequences after adm in istration of MR im aging contrast material are also useful in the evaluation of chemotherapy in patients w ith urinary bladder cancer. Initial results in 16 patients who received 3 X 2 MVAC chem otherapy treatments showed a reduction of tum or size on conventional un enhanced MR im ages in 10 patients (see Figs,  9A and I). This correlated w ith a response in eight patients and no response in two. In six patients, no decrease in tum or size w as visi ble on conventional MR im ages; how ever, two of these patients had complete response. In 10 p atients, fast dynam ic techniques show ed delayed tu m o r enhancem ent after only two MVAC treatments. In these patients, tum or enhancem ent started later than 1 0 sec onds after arterial enhancement, whereas be fore chem otherapy all tum ors started to en hance within 6 seconds. In all 10 of these patients, response to the chemotherapy oc curred (see Figs. 9C and 9ƒ ). In the remaining 6 patients, the enhancem ent persisted to be early, which correlated w ith no response.
Postprocessing
Progress in com puter technology will result in innovations in the postprocessing of the acquired data. Fast m u ltip lan ar im aging allows evaluation of three-dimensional data sets in every plane. Three-dimensional seg m entation techniques facilitate better visual ization and understanding of the spatial rela tionship b etw een n o rm a l and abnorm al structures (see Figs. 9E and 9F ). With the help of maximal intensity projections, vessels can be visualized w ith o u t the use of contrast agents. Other te cliniques show quantitative information about time, slope, and w ashout of tu m o r en h an cem en t in color, projected over the original images (see Figs. 923, 9C , and 9D).
the therapeutic m anagem ent and outcome. To obtain this goal knowledge of urologists of MR im aging an d knowledge of radiologists of clinical m anagem ent are needed; therefore, continuous education and communication be tw een these tw o specialties is a necessity.
